Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory.
about
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic IllnessModulation of learning and memory by cytokines: signaling mechanisms and long term consequencesPsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorActivation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in miceThe role of brain interleukin-1 in stress-enhanced fear learning.Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxietyA multispecies approach for understanding neuroimmune mechanisms of stress.Quantitatively and qualitatively different cellular processes are engaged in CA1 during the consolidation and reconsolidation of contextual fear memory.Novel aspects of glucocorticoid actionsEssential role of interleukin-15 receptor in normal anxiety behavior.p21Cip restrains hippocampal neurogenesis and protects neuronal progenitors from apoptosis during acute systemic inflammation.Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behaviorEndogenous IL-1 in cognitive function and anxiety: a study in IL-1RI-/- miceHeat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalonChronic intestinal inflammation alters hippocampal neurogenesis.ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human OriginImipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidanceThe inflammasome: pathways linking psychological stress, depression, and systemic illnessesThe effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice.Inflammasome-IL-1β Signaling Mediates Ethanol Inhibition of Hippocampal NeurogenesisEffect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome compositionPharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depressionThe biology of depression in cancer and the relationship between depression and cancer progression.β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeatStress-Induced Microglia Activation and Monocyte Trafficking to the Brain Underlie the Development of Anxiety and Depression.Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.Gene deficiency and pharmacological inhibition of caspase-1 confers resilience to chronic social defeat stress via regulating the stability of surface AMPARs.Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.Interleukin-15 receptor is essential to facilitate GABA transmission and hippocampal-dependent memory.Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responsesAmygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B.Microglial Over-Activation by Social Defeat Stress Contributes to Anxiety- and Depressive-Like Behaviors.Do omega-6 and trans fatty acids play a role in complex regional pain syndrome? A pilot study.Immune signaling mechanisms of PTSD risk and symptom development: insights from animal models.Hippocampal interleukin-1 mediates stress-enhanced fear learning: A potential role for astrocyte-derived interleukin-1β.
P2860
Q26765501-4408A875-D5D3-4D75-81C6-C274BA5D2DBDQ27023841-4766D1CF-FE48-401E-B3B1-EE2D9F9F57BBQ27694728-275C22A3-D0AC-4E1F-AB91-698DCC10B0D7Q28481373-92D52D70-0A77-463E-AE28-3DE99DC78392Q30387328-1E5A86EF-47A1-4FE3-97D4-D2D21DEEA6BFQ30471083-8AEA730A-DF15-433C-BB86-53807C1A4EB6Q30587153-4E851C6D-6C4F-4911-BF0F-4F00653CFDE9Q33721025-0BC632B9-996B-42BA-B607-2CC332300B4BQ33748040-102A1EB5-DE87-443E-91A4-D71149F1FBA8Q34169672-A42EF297-6F98-47E9-885B-7B09640465C3Q34172690-585A3C27-0C43-4981-9DA9-496B8E854C46Q34223531-4BBF0CEC-E173-43A1-89BB-C261A3CD03CFQ34369407-2D5A012C-65DB-4E3D-85EC-27F58252A399Q34991978-833A4FA7-9358-4A29-B9EC-4FA8B523AC0EQ35036400-5C475D1D-EE46-4751-867A-5D5664F1B45FQ35149520-5217E203-AC0D-4D99-83B4-375E9CC371B3Q35493761-B86500EE-0FF0-48D7-A037-2A420009E0D7Q35533016-18CEC306-98EB-497D-B2C2-9A9514331762Q35564868-6B3694E5-8AB1-4E4D-ABA8-90CF913B639DQ35592049-D1FD6BC3-9C3A-469A-BBAF-56FD42312452Q35624369-1831A342-863E-4B14-B76D-F17816AD9664Q35996491-71BE44CE-7D74-409B-B1CE-9DD59F51538AQ36026239-EAC78099-BCB3-48F6-BC84-29700A9919AAQ36904522-5E850E1E-FC08-4964-8D3A-A116DE9BB06AQ36932860-E5AEECD6-C7E7-4CF3-9183-64A99C5CAC96Q37219098-6EECEDA5-0AB1-425E-8C5B-0CD6403D0F46Q37223246-CF84D685-B976-470E-9D6D-BDC4BCB932ABQ38203302-B442372B-EDAB-48E9-B4E5-AF5B1A2888D2Q38254940-F85C6EEE-0B0D-4366-B5FE-36C5CE1F7568Q38879652-18222EFD-BD61-4A66-8082-03E1DF5D15A4Q39124105-D5DCE48F-8653-4CE1-8AC5-9E3810F0B51BQ39306011-93B7A30F-670B-432D-B7D5-430A37F02207Q39839633-5B2FD7D4-AF1A-43AB-973D-2F97D132CAD5Q40302599-FE908FA0-479A-4347-847E-F6F8892D7FB0Q41331414-80E2E0A0-0E9F-41DF-BD3B-4EA8C6BC7B4DQ44630690-8F42F211-E5D8-4AC2-ACF5-DBAD9E7E608BQ45369024-EF696672-1815-4896-851C-3D51A62A2806Q45893349-A0E6E7AB-E7EB-48C5-B50F-5A81D2235075Q46032008-E8465762-1313-4063-ADCE-D6FD9DF5A7CFQ47723553-6FC334C5-A12A-40F6-94E3-1CA450EDF5FA
P2860
Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Interleukin-1 receptor null mu ...... vior and enhanced fear memory.
@en
type
label
Interleukin-1 receptor null mu ...... vior and enhanced fear memory.
@en
prefLabel
Interleukin-1 receptor null mu ...... vior and enhanced fear memory.
@en
P2860
P1433
P1476
Interleukin-1 receptor null mu ...... vior and enhanced fear memory.
@en
P2093
Ja Wook Koo
Ronald S Duman
P2860
P356
10.1016/J.NEULET.2009.03.068
P407
P577
2009-03-27T00:00:00Z